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 Summary: Organism-wide RNA interference (RNAi) is due to the transport of mobile 
silencing RNA throughout the organism but the identities of these mobile RNA species in 
animals are unknown. Here we present genetic evidence that both the initial double-
stranded  RNA ( d s R N A ) ,  which t r i g g e r s  R N A i , a n d  a t  l e a s t  o n e  d s R N A  i n t e r m e d i a t e  
produced during RNAi can act as or generate mobile silencing RNA in Caenorhabditis 
elegans. This dsRNA intermediate requires the long dsRNA-binding protein RDE-4, the 
endonuclease DCR-1, which cleaves long dsRNA into double-stranded short-interfering 
RNA  (ds-siRNA),  and  the  putative  nucleotidyltransferase  MUT-2 ( RDE-3).  However, 
single-stranded siRNA and downstream secondary siRNA produced upon amplification 
by the RNA-dependent RNA Polymerase RRF-1 do not generate mobile silencing RNA. 
Restricting  inter-tissue  transport  to  long  dsRNA  and  directly  processed  siRNA 
intermediates rather than amplified siRNA may serve to modulate the extent of systemic 
silencing in proportion to available dsRNA. Intercellular transport of RNA has been inferred in plants and animals undergoing gene 
silencing  by  RNAi
1.  In  plants,  short-interfering  RNAs  (siRNA)  processed  from  long 
dsRNA  move  between  cells  through  intercellular  bridges  called  plasmodesmata  and 
travel long distances via the phloem to convey gene-specific silencing information
2,3,4. 
Although the nature of mobile silencing signals in animals is unknown, the conserved 
RNA transporter SID-1 is required for their import in Caenorhabditis elegans and has 
been implicated in RNA transport in other animals
5,6,7. In addition, dsRNA expressed in 
multiple tissues can generate sid-1-dependent mobile silencing RNA through an as yet 
unknown  pathway
8.  Since  animals  transcribe  dsRNA  from  numerous  loci
9, 
understanding  how  mobile  RNA  is  produced  from  dsRNA  has  broad  implications  for 
systemic control of gene expression. 
Multiple distinct RNA species are produced during RNAi in C. elegans, but, it is 
unclear  which  of  these  are m o b i l e  (Fig.  1a)
10,11,12,13.  These  RNA  species  include 
transcribed sense and anti-sense duplexes (dsRNA), double-stranded short-interfering 
RNA (ds-siRNA) generated upon cleavage of long dsRNA by the RDE-4–Dicer(DCR-1) 
complex, primary single-stranded siRNA generated upon cleavage of ds-siRNA by the 
Argonaute  RDE-1
13,  and  the  subsequent  numerous  secondary  siRNAs g e n e r a t e d  b y  
RNA-dependent RNA polymerases (RdRP) that are responsible for potent silencing of 
the  target  gene.  In  addition,  enzymes  that  can  modify  RNA  such  as  the  putative 
nucleotidyltransferase MUT-2
14,15,16, which is required for efficient RNAi (Supplementary 
Fig. 1), may also generate RNA species that act as mobile RNA. Early studies using 
dsRNA injected into the cytoplasm of gut cells suggested that RNA silencing in gut cells 
is  not  required  to  transport  a  mobile  silencing  signal  to  the  germline
17,18.  However, 
whether this signal is the injected exogenous dsRNA itself or a dsRNA-derived mobile 
RNA  or  both  is  unclear  and  how  endogenously  transcribed  dsRNA  leads  to  the 
production of mobile RNA is unknown. 
Here we determine the genetic requirements for silencing due to mobile RNAs 
using well-characterized promoters to restrict the expression of dsRNA or RNAi pathway 
genes to specific tissues and examining target gene silencing in other tissues. In most 
experimental systems that use similar approaches, it is difficult to control for low levels of 
misexpression  in the  target t i s s u e s .  Since  SID-1 i s  strictly  required  for  the  import  of 
mobile  silencing  RNAs
8,  SID-1-dependence  of  silencing  serves  to  clearly  distinguish 
silencing due to mobile RNA from silencing due to misexpression in the target tissues.  
 
RESULTS 
Long dsRNA is mobile in C. elegans 
We examined how endogenously transcribed dsRNA produces mobile silencing 
RNA using mosaic animals (i.e. animals that have some mutant cells and some wild-type 
cells) in which a mutant donor tissue expresses dsRNA that targets a gene in a wild-type 
recipient tissue (Fig. 1b). To determine whether the activity of the primary Argonaute 
RDE-1  is  required  to  produce  a  mobile  silencing  signal,  we  first  expressed  dsRNA 
targeting the green fluorescent protein (gfp) in the pharynx of rde-1(-) animals. We then 
coexpressed gfp and rde-1(+) in the body-wall muscle (bwm) cells, making bwm a wild-
type recipient tissue (Fig. 1c and Supplementary Fig. 2). We observed gfp silencing in 
anterior  rde-1(+) b w m  c e l l s .  T h u s ,  R N A i -mediated  silencing  in  the  pharynx  is  not 
required to produce and transport mobile RNA to the bwm cells. To determine whether 
RNAi pathway genes upstream of RDE-1 are required to produce a mobile silencing 
signal from expressed dsRNA, we developed a sensitive assay that measures silencing 
of  an  endogenous  gene  due  to  mobile  RNA  (Fig. 1 d  a n d  Supplementary  Fig.  2). 
Specifically, we introduced a neuronally expressed transgene that produces a ~560 bp 
dsRNA that targets the muscle gene unc-22 (neur::u22ds). All unc-22 silencing detected in animals with the neur::u22ds transgene required the RNAi pathway genes and the 
RNA  transporter  SID-1,  showing  that  all  silencing  occurred  through  RNAi  in  these 
animals  and  was  due  to  mobile  RNA e n a b l e d  R N A i  ( Fig. 1 d ).  Using  this  source  of 
mobile RNA, we detected unc-22 silencing in rde-4(-) animals that expressed rde-4(+) in 
bwm cells and in mut-2(-) animals that expressed mut-2(+) in bwm cells (Fig. 1e). Thus, 
neither dsRNA cleavage through RDE-4 recruitment of Dicer nor modification by the 
nucleotidyltransferase  MUT-2  is  required  in  neurons  that  express  dsRNA  for  the 
generation and export of mobile RNA. Together, these results show that a mobile RNA is 
generated from transcribed long dsRNA, independent of processing by the canonical 
RNAi pathway, can generate a mobile silencing RNA.  
 
A processed dsRNA also moves between cells 
To determine whether products of dsRNA processing by the canonical RNAi pathway 
are also mobile, we expressed dsRNA in a wild-type, RNAi proficient donor tissue and 
examined silencing in RNAi defective recipient tissues. If a processed RNA produced in 
the wild-type donor tissue can act as or generate a mobile silencing RNA, that RNA may 
bypass  the  lack  of  the  earlier-acting  RNAi  pathway  gene  in  the  recipient  tissue  and 
cause silencing. Note that using this approach we cannot infer anything about RNAs that 
move between tissues but that fail to cause gene silencing.  
To  detect  silencing  triggered  by  mobile  processed  RNAs  we  rescued  RNAi 
pathway mutants only in neurons of animals that contain the neur::u22ds transgene and 
measured  unc-22  silencing  in  the  mutant  target  muscle  cells.  We  detected  unc-22 
silencing  in  rde-4(-) a n i m a l s  t h a t  e x p r e s s e d  rde-4(+) i n  n e u r o n s .  Consistent  with 
silencing due to mobile RNAs, SID-1 is required for the observed silencing (Fig. 1f). 
Since  RDE-4  is  required f o r  D C R -1  cleavage  of  long  dsRNA  into  ds-siRNA
19,  these 
mobile RNAs are either ds-siRNA or downstream RNAi products. To distinguish between 
these two possibilities, we similarly examined the role of the primary Argonaute RDE-1 in 
the production of mobile RNA. In contrast to the analogous experiment with RDE-4, we 
observed  no  detectable  unc-22  silencing  in  rde-1(-) a n i m a l s  t h a t  e x p r e s s  rde-1(+) i n  
neurons. This observation suggests that primary siRNA and downstream RNAi products 
such as RdRP-dependent secondary siRNA are not mobile. Finally, we detected unc-22 
silencing  in  mut-2(-) a n i m a l s  t h a t  e x p r e s s e d  mut-2(+) i n  neurons  (Fig.  1f)  and  this 
silencing was due to mobile RNA since it required SID-1 (Fig. 1d). Therefore, we infer 
that like RDE-4, MUT-2 functions upstream of RDE-1 to generate a species of mobile 
RNA that can bypass the need for MUT-2 activity in the recipient tissue.  
 
Mobile RNAs are similarly made from other sources of dsRNA.  
We next tested whether other sources of silencing RNAs also rely on the same genes to 
produce mobile RNAs. Multicopy transgenes such as sur-5::gfp (which express nuclear-
localized GFP in all somatic tissues) can generate mobile RNAs, presumably from trace 
amounts  of  dsRNA  produced  from  the  transgene
8,20.  We  therefore  generated  rde-4(-
);sur-5::gfp animals and moved a representative transgene that expresses rde-4 in bwm 
cells (bwm::rde-4(+)) into these animals. Significant silencing (P<0.05) was detected in 
non-muscle tissues in the resultant mosaic animals and was most easily observed in the 
prominent gut nuclei (Fig. 2a,b). Consistent with silencing due to mobile RNAs, SID-1 is 
required for the observed silencing of gut nuclei (Fig. 2c,d). However, when we moved a 
representative transgene that expressed rde-1(+) in bwm cells (bwm::rde-1(+)) into rde-
1(-); sur-5::gfp animals, we observed no detectable silencing of GFP expression in the 
gut. In contrast, moving a representative transgene that expressed mut-2(+) in bwm cells 
(bwm::mut-2(+))  into  mut-2(-);  sur-5::gfp a n i m a l s  r e s u l t e d  i n  t h e  s i l e n c i n g  o f  G F P  
expression  in  the  gut  (Fig.  2d).  The  observed  silencing  was  dependent  on  SID-1, showing  that  mobile  RNA  triggered  the  silencing  in  mut-2(-)  gut  cells  (Fig.  2d). 
Therefore,  as  in  the  case  of  expressed  dsRNA,  multicopy  transgenes  also  generate 
mobile RNAs that are upstream of RDE-1 and include those that are processed by RDE-
4 and MUT-2.  
We next tested whether RDE-4 and MUT-2 but not RDE-1 can similarly process 
exogenously supplied dsRNA to produce mobile RNA. We fed bacteria that express gfp-
dsRNA  (feeding  RNAi)
21  to  the a b o v e  rde-1(-),  rde-4(-),  and  mut-2(-)  mutants  that 
contain the sur-5::gfp t ransgene and  that are rescued in muscle cells and exami ned 
silencing  in  the  respective  mutant  gut  cells.  Consistent  with  our  results  with 
endogenously transcribed dsRNA, we found that gfp feeding RNAi increased silencing of 
GFP in the non-muscle cells of muscle-rescued rde-4(-) and mut-2(-) animals but not of 
muscle-rescued  rde-1(-) a n i m a l s  ( Fig.  3a).  To  assay  silencing  due  to  feeding  RNAi 
targeting endogenous genes, we removed the sur-5::gfp transgenes from the transgenic 
bwm  rescue  lines  and  then  fed  these  muscle-rescued  animals  bacteria  that  express 
dsRNA targeting the muscle gene unc-22 or that express dsRNA targeting the skin gene 
dpy-7 or that express dsRNA targeting the intestinal gene act-5. Silencing due to feeding 
RNAi  of  these  endogenous  genes  was  consistent  with  our  results  using  gfp f e e d i n g  
RNAi  and  using  endogenously t r a n s c r i b e d  d s R N A .  Specifically,  while  we  observed 
robust  silencing  of  the  muscle  gene  in  all  three  strains  of  muscle-rescued  animals, 
silencing of the skin and intestinal genes was detectable in muscle-rescued rde-4(-) and 
mut-2(-) animals (Fig. 3b) but not in muscle-rescued rde-1(-) animals (Fig. 3b, ref. 22). 
Thus, the silencing observed in these rde-4 and mut-2 mosaic animals by feeding RNAi 
is likely due to import of ingested long dsRNA into the rescued muscle cells followed by 
export of a processed mobile RNA that can silence the target genes in rde-4(-) and mut-
2(-) c e l l s .  Therefore,  both  multicopy  transgenes  and  ingested  dsRNA  use  the  same 
genetic pathway to produce short mobile silencing RNA.  
 
Two classes of upstream dsRNAs are mobile RNAs 
Taken together, our results suggest a model whereby upstream dsRNA species such as 
long dsRNA and ds-siRNA act as or generate mobile RNA, while all silencing RNAs 
produced after cleavage of ds-siRNA by RDE-1 cannot cause silencing in rde-1(-) cells 
(Fig. 4a). Since Dicer can cleave long dsRNA in the absence of MUT-2
12 and since 
MUT-2 acts upstream of RDE-1 to generate mobile RNA, one possible role for MUT-2 in 
RNAi is to modify ds-siRNA. Despite MUT-2 having the required catalytic residues, a 
systematic test of putative nucleotidyltransferases using in vitro assays failed to reveal 
how  MUT-2  might  modify  RNA
23.  Nevertheless,  consistent  with  our  model, 
overexpression  of  neither  mut-2(+) n o r  rde-4(+) i n  b w m  c e l l s  o f  rde-1(-);  sur-5::gfp 
animals  resulted  in  detectable  silencing  (Supplementary T a b l e  1 ).  Further,  neither 
overexpression  of  mut-2(+) i n  b w m  c e l l s  o f  rde-4(-);  sur-5::gfp a n i m a l s  n o r  
overexpression of rde-4(+) in the bwm cells of mut-2(-);sur-5::gfp animals resulted in 
detectable silencing (Supplementary Table 1), suggesting that RDE-4 and MUT-2 act in 
the same pathway to generate mobile RNA. 
The following tests provide additional support for the model that long and short 
dsRNAs, but not single-stranded siRNA act as mobile silencing RNA: (1)  The RdRP 
RRF-1, which makes numerous downstream secondary siRNAs, is not required for the 
generation  of  mobile  RNAs  (Fig.  4b);  (2)  Rescuing a  p a r t i a l  l o s s -of-function  dcr-1 
mutant
24 in the recipient tissue (which increases processing of imported Dicer precursors 
[long dsRNA]) improves silencing, presumably of imported long dsRNA (Fig. 4b); (3) 
Rescuing the dcr-1 mutant in donor tissues also increased silencing in recipient cells, 
presumably  by  increased  transport  of  ds-siRNA  (Fig.  4b);  and  (4)  expression  of Inhibitors of RNAi in recipient cells, including the conserved exonuclease ERI-1 that can 
degrade ds-siRNA
25, inhibited silencing  (Supplementary Fig. 3). 
 
DISCUSSION 
We provide evidence for the existence of at least two distinct species of mobile RNA in 
C. elegans: one that is produced from long dsRNA independent of RNAi genes in donor 
tissues but requires all tested RNAi genes for silencing in recipient tissues and one that 
requires RDE-4, DCR-1, and MUT-2 for production in donor tissues but not for silencing 
in recipient tissues.  
 
Animal mobile silencing RNAs differ from plant mobile RNAs 
In plants, mobile RNAs move between cells through relatively non-selective intercellular 
bridges called plasmodesmata
2,3. In the plant Arabidopsis, grafting experiments between 
genetically distinct source and target tissues have enabled the molecular identification of 
mobile RNAs.  These studies have identified both single-stranded siRNA and ds-siRNA 
whose  movement  to  distant  tissues  correlates  with  mobile  RNAs
2,3.  I n  a d d i t i o n ,  
accumulating evidence supports the intercellular movement of microRNAs, tasiRNAs, 
and mRNAs
26. 
Our results indicate that in C. elegans, long dsRNA and a form of ds-siRNA can 
move  between  cells  (Fig.  4a).  Unexpectedly,  and  in  contrast  to  what  is  observed  in 
plants, single-stranded siRNAs produced by RdRP amplification are either not mobile, or 
if mobile, are incapable of causing detectable silencing in recipient cells. Consistent with 
mobile  silencing  signals  being  restricted  to  double-stranded  forms  of  RNA,  most 
systemic  RNAi  silencing  observed  in  C.  elegans i s  d e p e n d e n t  o n  SID-1
5,8,  which  is 
exquisitely selective for dsRNA
27. This restriction couples the extent of RNAi spreading 
to the amount of primary dsRNA produced within cells or imported from the environment.  
 
A conserved pathway to make animal mobile RNAs  
Since a mammalian SID-1 homolog can transport ds-siRNAs into mammalian cells
7, ds-
siRNA, perhaps modified by a nucleotidyltransferase, may move between mammalian 
cells. Importantly, short dsRNAs can escape the interferon response that results in non-
specific  effects  in  differentiated  mammalian  cells
28,  thus  their  transport  between 
differentiated tissues should be tolerated. In contrast, the transport of long dsRNA will 
result in specific gene silencing only in undifferentiated mammalian cells. Furthermore, 
the protein activities required to make short mobile RNA in worms are found in most 
animals: dsRNA-binding proteins, such as RDE-4, that act with Dicer (e.g. PACT and 
TRBP with human Dicer
29) and β-nucleotidyltransferases, such as MUT-2, that play a 
role in RNA silencing
14,15,16. Modulation of such conserved biochemical pathways may 
contribute  to  the  tissue- a n d  e n v i r o n m e n t -dependent  differences  in  silencing  due  to 
mobile RNA that are observed in C. elegans
30,8. Regulated transport of mobile RNA is 
evident in plants, where mobile RNA produced in metabolic source tissues control gene 
expression in distant metabolic sink tissues
31. Similarly, C. elegans mobile RNAs are 
preferentially imported into cells that express SID-1 at high levels
32,8, suggesting that 
SID-1 expression produces a sink for mobile RNA. Therefore, short dsRNAs produced 
from endogenous loci in a mammalian cell may control gene expression in another cell 
type that expresses a SID-1 homolog.  
 
Note:  Supplementary  Information  is  available  on  the  Nature  Structural  &  Molecular 
Biology website.  
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Figure Legends 
 
Figure  1  RNAi-independent  biogenesis  of  mobile  RNA  from  expressed  dsRNA.  (a) 
Schematic of RNAi within a cell. See text for details. (b) Schematic of assay to measure 
silencing due to mobile RNA. dsRNA that targets a gene in recipient cells are expressed 
only in other donor cells. (c) A representative rde-1(-) L4 animal that expresses gfp-
hairpin RNA only in the pharynx (phar::hp-gfp) but gfp in pharynx and bwm cells (left 
panel) and one that in addition coexpress rde-1(+) and DsRed only in bwm cells (right 
panel). 100% of animals from three independent bwm::rde-1(+) & DsRed lines showed 
silencing  as  above.  Scale  bar,  50  µm.  (d-f) A  r e p r e s e n t a t i v e  t r a n s g e n i c  l i n e  t h a t  
expresses  unc-22-dsRNA  under  the  control  of  the  neuronal  rgef-1 p r o m o t e r  
(neur::u22ds)  was  generated  in  wild-type  animals  and  crossed  into  the  genetic 
backgrounds indicated. The uncoordinated twitching (Unc) due to the silencing of unc-22 
was  measured  in  these  animals  (black)  and  in  animals  that  in  addition  had t h e  
corresponding RNAi gene rescued in body-wall muscles (white) or in neurons (blue). 
n=100  animals;  error  bars  indicate  95%  confidence  intervals;  and  asterisks  indicate 
significant  differences  (P<0.05).  Partial  silencing  in  rescued  transgenic  lines  likely 
indicate  that  levels  of  the  rescuing  genes  are  inadequate  for  complete  silencing  in 
response  to  the  low  levels  of  neuronal  unc-22 d s R N A .  C o n s i s t e n t l y ,  f e e d i n g  unc-22 
dsRNA  to  animals  with  the  same  muscle-rescued  transgenic  lines  above  results i n  
complete silencing (Fig. 3). See Supplementary Fig. 2 for details of constructs used. 
 
Figure 2 Restricted expression of RDE-4 and MUT-2 but not RDE-1 enables non-cell 
autonomous RNA silencing. (a-c) Representative animals that express nuclear-localized 
GFP in all cells (sur-5::gfp). (a) rde-4(-). (b) rde-4(-) animals with rde-4(+) and DsRed 
expressed in bwm cells (qtEx[bwm::rde-4(+) & DsRed]). (c) rde-4(-) animals that only 
express  DsRed  in  bwm c e l l s  ( qtEx[bwm::DsRed]).  Brackets  indicate  silencing  in  gut 
nuclei. Insets are widefield (a) or red channel (b, c) images. Scale bars, 50 µm. Note 
that unlike overexpression of rde-4(+), overexpression of the coinjection marker DsRed 
did  not  result  in  any  silencing  of  gfp e x p r e s s i o n  [compare  (b)  and  (c)]. W h e n  
coexpressed  with  rde-4(+),  DsRed e x p r e s s i o n  w a s  l o w e r  ( e n h a n c e d  i n  ( b) i n s e t  t o  
clearly indicate expression in the bwm), which likely reflects enhanced silencing of the 
DsRed transgene. (d) The number of brightly fluorescent gut nuclei that show sur-5::gfp 
expression were counted in rde-1(-), rde-4(-), and mut-2(-) mutant backgrounds as well 
as in mutant animals with a corresponding representative bwm rescue transgenes from 
Fig. 1e. Similar experiments done with rde-4(-); sid-1(-) and mut-2(-); sid-1(-) double 
mutant backgrounds are also shown. n=25 L4 animals. Averages (red bars), significant 
differences (brackets and *, P<0.05) and similar values (brackets) are indicated. Minor 
variations in the average number of nuclei (± 2 nuclei) observed between animals were 
not due to silencing of gfp expression but rather due to small changes in the number of 
intestinal nuclei (see Supplementary Fig. 4 and the discussion therein). 
 
Figure 3 RDE-4 and MUT-2 but not RDE-1 processed ingested dsRNA is mobile. (a) 
Feeding  RNAi  of  rde-1(-),  rde-4(-), a n d  mut-2(-) a n i m a l s  w i t h  sur-5::gfp a n d  their 
corresponding representative bwm rescue transgenic lines used in Fig. 2d. The number 
of brightly fluorescent gut nuclei that show  sur-5::gfp expression were counted in L4 
animals that were fed either control bacteria (brown, re-plotted from Fig. 2d) or bacteria 
expressing gfp-dsRNA (blue). n=25 animals. Averages (red bars), significant differences 
(brackets and *, P<0.05) and similar values (brackets) are indicated. (b) Feeding RNAi of 
strains in (a) after removal of sur-5::gfp. L4 animals were fed L4440 (control) or dsRNA targeting the muscle gene unc-22 (bwm) or the skin gene dpy-7 (skin) or the gut gene 
act-5 (gut) and the percentage of L4 progeny that showed the corresponding defects 
were determined. n=100 L4 animals; error bars indicate 95% confidence intervals. 
 
Figure  4  Biogenesis  of  mobile  RNA  in  C.  elegans.  (a)  Schematic  of  the  biogenesis 
pathway.  Double-stranded  forms  of  RNA  produced  during  the  early  steps  of  RNA 
interference act as or generate mobile RNAs. RNAs produced after the Argonaute RDE-
1  cleaves  ds-siRNA  to r e l e a s e  s i n g l e  s t r a n d e d  R N A
13 a r e  r e s t r i c t e d  t o  i n t r a c e l l u l a r  
silencing. MUT-2 expression enables the generation and export of mobile RNA possibly 
through enzymatic modification of dsRNA. Since expressed as well as ingested dsRNA 
generate mobile RNA, additional regulation in response to the environment and selection 
of  specific  endogenous  loci  to  make  mobile  RNAs i s  l i k e l y .   (b)  RdRP  activity  is  not 
required  for  mobile  RNA  production  and  dsRNAs  both  upstream  and  downstream  of 
Dicer generate mobile RNAs. The representative transgene used in Fig. 1 to express 
unc-22-dsRNA  under  the  control  of  the  neuronal  rgef-1 p r o m o t e r   (neur::u22ds)  was 
crossed into the genetic backgrounds indicated. Two deletion alleles of rrf-1 (pk1417 & 
ok589) were rescued with rrf-1(+) in bwm and the missense allele dcr-1(bp132) was 
rescued with dcr-1(+) in the bwm and in neurons. Silencing of unc-22 was measured (% 
Unc) in the mutant animals (black) and in animals with the corresponding RNAi gene 
rescued in bwm (white) and in neurons (blue). n=100 animals. 95% confidence intervals 
(error  bars)  and  significant  differences  (brackets  and  *,  P<0.05)  are  indicated.  See 
Supplementary Fig. 2 for details of constructs used.  
 
 
ONLINE METHODS 
 
Strains Used.  N2  wild-type,  HC196  sid-1(qt9),  WM30 mut-2 or  rde-3(ne298),  WM27 
rde-1(ne219), WM49 rde-4(ne301), NL2099 rrf-3(pk1426), GR1373 eri-1(mg366), HC70 
rde-1(ne219);  mIs11[Pmyo-2::gfp];  ccIs4251[Pmyo-3::gfp];  qtIs3[Pmyo-2::hp-gfp], 
PD4792 mIs11[myo-2::GFP, gut::GFP, pes-10::GFP], HC195 nrIs20[sur-5::gfp], HC731 
sid-1(qt9);  eri-1(mg366),  HC732  sid-1(qt9);  rrf-3(pk1426),  HC733  mut-2(ne298);  sid-
1(qt9);  nrIs20,  HC734  sid-1(qt9);  rde-4(ne301);  nrIs20,  HC735  mut-2(ne298);  mIs11, 
HC736  qtEx136[Prgef-1(F25B3.3)::unc-22sense;  Prgef-1::unc-22antisense;  Prgef-
1::DsRed line 8], HC737 rde-4(ne301); nrIs20, HC738 rde-1(ne219); nrIs20, HC739 mut-
2(ne298);  nrIs20,  HZ202  dcr-1(bp132);  wIs51[scm-1::GFP]
24,  RB798  rrf-1(ok589), 
NL2098  rrf-1(pk1417),  HC779  dcr-1(bp132)  [outcrosssed  with  N2 t w i c e ],  HC780  rrf-
1(ok589) [outcrossed with N2 twice], HC781 rrf-1(pk1417) [outcrossed with N2 twice], 
HC782 sid-1(qt9) rde-1(ne219), HC783 sid-1(qt9); rde-4(ne301), HC784 sid-1(qt9); mut-
2(ne298). 
 
Strain  constructions a n d  t r a n s g e n i c  a n a lyses. D o u b l e  m u t a n t s  w e r e  m a d e  u s i n g  
standard genetic approaches and were verified by genotyping using DNA sequencing or 
PCR analysis. Additional strains were constructed by crossing representative transgenes 
into various genetic backgrounds. These include strains generated by crossing HC736 
into either single mutants (WM27, HC196, WM27, WM49, NL2099, GR1373, HC779, 
HC780,  HC781)  or  double  mutants  (HC731,  HC732,  HC782,  HC783,  HC784;  by 
crossing a representative line that coexpresses rde-4(+) and DsRed2 in bwm cells of 
WM49 into HC734 and HC737; by crossing a representative line that coexpresses rde-
1(+) and DsRed2 in bwm cells of WM27 into HC738; by crossing a representative line 
that  coexpresses  mut-2(+) a n d  D s R e d 2   in  the  bwm  cells  of  WM30  into  HC733  and 
HC739; and by crossing a representative line that coexpresses gfp-dsRNA and DsRed2 in the pharynx of HC195 and PD4792 into HC739 and HC735, respectively. To avoid 
bias due to observed phenotypic defects, cross progeny or re-homozygosed progeny 
were either selected using the DsRed2 co-injection markers or selected randomly and 
the genotype was determined subsequently by PCR.  
30-35  animals  from  three i n d e p e n d e n t  t r a n s g e n i c  rescue  lines  were  analyzed 
(n=100) in all cases except for the rescue of rde-4(+) in neurons of rde-4(-) animals, 
where  a  representative  rescue  line  was  crossed  into  rde-4(-) a n i m a l s  w i t h  t h e  
neur::u22ds transgene and 100 double-transgenic animals were analyzed. 
 
Microscopy. Fluorescent images shown are projections of Z-series that were acquired 
using a Ziess spinning-disc confocal microscope except in Supplemental Fig. 1a, where 
widefield fluorescent images taken using a dissecting fluorescent microscope are shown. 
Images for strains that are being compared in all figures were acquired under the same 
non-saturating exposure conditions and, with the exception of the DsRed inset in Fig. 
2b, then adjusted identically using Image J (NIH) and Photoshop (Adobe) software for 
display.  
 
RNAi assays. To measure the extent of GFP silencing, we used a dissecting fluorescent 
microscope to count the number of brightly fluorescent gut nuclei in animals of the fourth 
larval stage (L4 stage) that are visible at a fixed magnification. The 2 nuclei that are 
located below 2 other nuclei in the first segment of the intestine (Int 1) are not easily 
resolved at this level of magnification and were not counted in this assay. Silencing in 
Fig. 1c was measured at 25°C, since some silencing of pharyngeal GFP is observed at 
lower  temperatures,  which  is  consistent  with  previous  reports  of  RDE-1-independent 
silencing
20. For feeding RNAi, L4-staged animals were fed bacteria that express L4440 
control  dsRNA  or  dsRNA  matching  a  target  gene  on  agar  plates  that  contain  1mM 
isopropyl  β-D-1-thiogalactopyranoside  (IPTG).  The  percentage  of  the  resultant  L4 
progeny that showed the corresponding defects was determined. For act-5 silencing, the 
number of animals that survive beyond L4 on day 5 for each genotype are expressed as 
a percentage of L4 and older animals on day 5 of the same genotype on L4440. To 
measure unc-22 silencing in response to expressed unc-22-dsRNA or unc-22 feeding 
RNAi,  we  determined  the  percentage  of  L4-staged  animals  that  twitched  within  3 
minutes  in  3  mM  levamisole ( S i g m a  A l d r i c h ) o r  o n  R N A i  f e e d i n g  p l a t e s  w i t h o u t  
levamisole, respectively. 
 
DNA constructs and transgenic animals. PCR fragments for transgenic expression
33 
and transgenic animals
34 were generated using standard methods as in ref. 8. Briefly, 
PCR fragments corresponding to the coding sequences and 3´UTR were amplified and 
fused to promoter sequences using overlap extension PCR
32. These fragments were 
then purified using a PCR clean-up column (Qiagen) and injected along with appropriate 
co-injection markers into C. elegans to generate transgenic lines. The specific primers 
used for PCR (Supplementary Table 2) and the specific concentrations and co-injection 
markers used for injections are detailed in Supplementary Information. 
 
Statistical Analysis. Statistical significance of differences in average numbers of gut 
nuclei  was c a l c u l a t e d  u s i n g  S t u d e n t ’ s  t-test.  For  all  other  assays,  95%  confidence 
intervals for single proportions were calculated using Wilson’s estimates with continuity 
correction
35  and  significant  differences  were  determined  using  Wilson’s  pooled 
estimates.  
 
Methods-only References 33.  Hobert,  O.  PCR  fusion-based  approach  to  create  reporter  gene  constructs  for 
expression analysis in transgenic C. elegans. Biotechniques 32, 728-730 (2002).  
34. Mello, C. C., Kramer, J. M., Stinchcomb, D., & Ambros, V. Efficient gene transfer in 
C. elegans: extrachromosomal maintenance and integration of transforming sequences. 
EMBO J 10, 3959-3970 (1991). 
35.  Newcombe,  R.  G.  Two-sided  confidence  intervals  for  the  single  proportion: 
Comparison of seven methods. Statist. Med. 17, 857-872 (1998). 
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 Figure 4  Two classes of silencing RNAs move between C. elegans tissues. 
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Supplementary F i g u r e  1  M U T -2  is  required  for  efficient  RNAi.  (a)  Representative 
images  of  the  pharynx  of  wild-type  and  mut-2(-) a n i m a l s  t h a t  e x p r e s s  G F P  i n  t h e  
pharynx  (left  panels)  and  that  in  addition  coexpress  gfp-dsRNA  and  DsRed  in  the 
pharynx (middle and right panels). The representative animals presented in these grey 
scale images show that wild-type animals silence gfp expression (green channel) more 
potently  than  mut-2(-) a n i m a l s  e v e n  i n  r e s p o n s e  t o  l o w e r  l e v e l s  o f  gfp-dsRNA  (red 
channel).  (b) F e e d i n g  R N A i  o f  w i l d -type  and  mut-2(-) a n i m a l s .  L4  animals  were  fed 
either L4440 (control) or dsRNA targeting the body-wall muscle gene unc-22 (bwm) or 
the  skin  gene  dpy-7 ( s k i n )  a n d  t h e  p e r c e n t a g e  o f  L 4  p r o g e n y  t h a t  s h o w e d  t h e  
corresponding defects were determined. Error bars indicate 95% confidence intervals 
and asterisks indicate significant differences (P>0.05). (c) A representative transgene 
that expresses gfp-dsRNA in the pharynx (phar::gfp-dsRNA) in sur-5::gfp animals was 
crossed  into  mut-2(-);  sur-5::gfp a n i m a l s  a n d  t h e  n u m b e r  o f  b r i ghtly  fluorescent  gut 
nuclei  were  counted.  n=25  L4  animals.  Averages  (red  bars),  significant  differences 
(brackets and *, P<0.05) and similar values (brackets) are indicated.  
	 ﾠ
Supplementary Figure 2 Schematics of constructs used and inheritance of silencing in 
the transgenic strain used in Fig 1. (a-b) Structures of unc-22 and RNAi pathway genes. 
Thin line, introns; thick line, exons; and red line, dsRNA sequence.  Regions amplified to 
rescue each RNAi pathway gene are indicated below gene structures as thin lines with 
terminal circles (primer positions). Open brackets indicate start of the gene 3’ to RNAi 
pathway gene. (c) L4 animals of the representative neur::u22ds transgenic line used in Fig. 1  i n  w i l d -type  and  eri-1(-) b a c k g r o u n d  w e r e  a l l o w e d  t o  h a v e  p r o g e n y .  Unc-22 
silencing was measured as in Fig. 1 in L4 staged progeny that either have or do not 
have the neur::u22ds transgene as indicated by presence or lack of DsRed expression, 
respectively. Error bars indicate 95% confidence intervals.  
 
Supplemental Figure 3 Inhibitors of RNAi reduce silencing due to mobile RNAs. The 
representative transgene used in Fig. 1 to express unc-22-dsRNA under the control of 
the neuronal rgef-1 promoter (neur::u22ds) was crossed into the single- and double-
mutant  backgrounds  indicated.  Silencing  of  unc-22 w a s  m e a s u r e d  ( %  U n c )  i n  t h e s e  
animals and in animals with the corresponding RNAi gene rescued in bwm of single 
mutants.  n=100 L 4  a n i m a l s .  95%  confidence  intervals  (error  bars)  and  significant 
differences  (brackets  and  *,  P<0.05)  are  indicated.  See  Supplementary  Fig.  2  for 
details of constructs used.  
 
Supplemental Figure 4 Variation in number and morphology of gut nuclei as indicated 
by sur-5::gfp expression. (a) sur-5::gfp expression in a wild-type L4 animal with normal 
gut  nuclei  indicated  by  lines.  (b)  sur-5::gfp e x p r e s s i o n  i n  a  rde-4(-) L 4  a n i m a l  w i t h  
regions of supernumerary (lines) and fewer (bracket) nuclei than normal. The reason for 
the variations in the number of sur-5::gfp-marked nuclei is currently unclear. Animals 
such  as  those  in  (b) o c c u r  i n  t h e  c a s e  o f  v a r i o u s  g e n o t y p e s ,  i n c l u d i n g  w i l d -type, 
suggesting that the reason for this variation is likely environmental. Interestingly, a role 
for RNAi-related genes and retinoblastoma genes in the control of nuclear divisions in 
the C. elegans gut has been demonstrated
36. Scale bar, 50 µm. 
Supplementary T a b l e  1  I n t e r d e p e n d e n c e  o f  R N A i  p a t h w a y  g e n e s  f o r  m o b i l e  R N A  
production.  
Genotype  % animals with gut silencing (n>100)
a 
rde-1(-); sur-5::gfp; qtEx[bwm::mut-2(+)]  0 
rde-1(-); sur-5::gfp; qtEx[bwm::rde-4(+)]  0 
rde-4(-); sur-5::gfp; qtEx[bwm::mut-2(+)]  0 mut-2(-); sur-5::gfp; qtEx[bwm::rde-4(+)]  0 
aIn each case, more than 20 animals from each of five transgenic lines were examined 
and the percentage of animals showing detectable silencing of GFP expression in the 
gut was measured. 
Supplementary Table 2 Primers used for PCR 
P1  CGAGGCATTTGAATTGGGGG  
P2  CGTTCTCGGAGGAGGCCATCCGAATCGATAGGATCTCGG  
P3  CCGAGATCCTATCGATTCGGATGGCCTCCTCCGAGAACG  
P4  CGGTCATAAACTGAAACGTAAC  
P5  GGTGGTGGACAGTAACTGTC  
P6  CTGAAACGTAACATATGATAAGG  
P7  CGATAATCTCGTGACACTCG 
P8  CGTTCTCGGAGGAGGCCATCGTCGTCGTCGTCGATGC 
P9  GCATCGACGACGACGACGATGGCCTCCTCCGAGAACG 
P10  CGATAATCTCGTGACACTCG 
P11  GAAAAGTTCTTCTCCTTTACTCATCGTCGTCGTCGTCGATGC 
P12  GCATCGACGACGACGACGATGAGTAAAGGAGAAGAACTTTTC 
P13  CAATGTTGCCAAATCACTTTCGCGTCGTCGTCGTCGATGC 
P14  GCATCGACGACGACGACGCGAAAGTGATTTGGCAACATTG 
P15  CTTGATTTGGAATGGAACCTTC  
P16  GGAACCTTCACAACACATGG  
P17  GAAGGTTCCATTCCAAATCAAGCGTCGTCGTCGTCGATGC 
P18  GCATCGACGACGACGACGCTTGATTTGGAATGGAACCTTC 
P19  CGAAAGTGATTTGGCAACATTG  
P20  GGCAACATTGGAGACTGATG  
P21  GGTCGGCTATAATAAGTTCTTG  
P22  CGGGAAAATTCGAGGACATCAAGGGTCCTCCTGAAAATG 
P23  CATTTTCAGGAGGACCCTTGATGTCCTCGAATTTTCCCG 
P24  GTGAAATCACCTGCAGAGAG 
P25  CCCGACAAAACATGAGTATTTC  
P26  CACCTGCAGAGAGAAAACATTTT 
P27  GATCTTTATTTGGTTGAGACATCAAGGGTCCTCCTGAAAATG 
P28  CATTTTCAGGAGGACCCTTGATGTCTCAACCAAATAAAGATC 
P29  CCTTGCTAGTTATCGTCTCC 
P30  AGTTATCGTCTCCGTAATTCG 
P31  CGTTAGTTTGGTTAAATCCATCAAGGGTCCTCCTGAAAATG 
P32  CATTTTCAGGAGGACCCTTGATGGATTTAACCAAACTAACG 
P33  CACTGCAGAGAATGAGTGTG 
P34  GTAGAGGTCAGAGGCATAG 
P35  ATCATTATCAAACGGGAGCATCAAGGGTCCTCCTGAAAATG 
P36  CATTTTCAGGAGGACCCTTGATGCTCCCGTTTGATAATGAT 
P37  CTGTGAGCAGTAGTACAAGTG 
P38  GCAGTAGTACAAGTGAACCG 
P39  CGGCTCATCTGCGCTCATCAAGGGTCCTCCTGAAAATG 
P40  CATTTTCAGGAGGACCCTTGATGAGCGCAGATGAGCCG 
P41  GCAAGACCGATAATAGAGGAT 
P42  ACTGAAAACGCCAGAAACTAG 
P43  CGGGAAAATTCGAGGACATCGTCGTCGTCGTCGATGC 
P44  GCATCGACGACGACGACGATGTCCTCGAATTTTCCCG 
P45  GATCTTTATTTGGTTGAGACATCGTCGTCGTCGTCGATGC P46  GCATCGACGACGACGACGATGTCTCAACCAAATAAAGATC 
P47  CGTTAGTTTGGTTAAATCCATCGTCGTCGTCGTCGATGC 
P48  GCATCGACGACGACGACGATGGATTTAACCAAACTAACG 
P49  CCATGACTTCGTTCCGACATCAAGGGTCCTCCTGAAAATG 
P50  CATTTTCAGGAGGACCCTTGATGTCGGAACGAAGTCATGG 
P51  GGCTTACCTGGTATCTTTGATC 
P52  ACCTGGTATCTTTGATCTCTG 
P53  CAGCTCTTACCCTGACCATCAAGGGTCCTCCTGAAAATG 
P54  CATTTTCAGGAGGACCCTTGATGGTCAGGGTAAGAGCTG 
P55  GCAGACTTCTTATCGGTGTG 
P56  CAGCTCTTACCCTGACCATCGTCGTCGTCGTCGATGC 
P57  GCATCGACGACGACGACGATGGTCAGGGTAAGAGCTG 
Supplementary Methods  
DNA constructs and transgenic animals. Co-injection markers: (a) pHC183
5: Plasmid 
with the myo-3 promoter cloned 5’ of DsRed2 cDNA. 
(b) pHC488: The myo-2 promoter region was amplified from genomic DNA with 
the  primers  P1  and  P2.  The  DsRed2 c o d i n g  s e q u e n c e  a l o n g  w i t h  unc-54 3 ´UTR 
sequence was amplified from pHC183 with primers P3 and P4. The fusion product was 
generated  with  P5  and  P6  and  then  cloned  into a  T / A  c l o n i n g  v e c t o r  ( S t r a t a C l o n e ,  
Stratagene) to make pHC488.  
(c)  Prgef-1::DsRed:  The  rgef-1 p r o m o t e r  w a s  a m p l i f i e d  w i t h  P 7  a n d  P 8 .  T h e  
DsRed2 c o d i n g  s e q u e n c e  a l o n g  w i t h  unc-54 3 ´UTR  sequence  was  amplified  from 
pHC183 using P9 and P4. The fusion product was generated with P10 and P6.  
To express gfp-dsRNA in pharyngeal muscles: Pmyo-2::gfp-sense, and Pmyo-
2::gfp-antisense were made as in ref. 8. A 1:1 mix of Pmyo-2::gfp-sense and Pmyo-
2::gfp-antisense (0.01 mg/ml each) along with pHC488 (0.038 mg/ml) was injected into 
HC195 and PD4792 animals to generate transgenic lines. 
To express unc-22-dsRNA in neurons (neur::u22ds): (a) Prgef-1::unc-22sense: 
The rgef-1 promoter was amplified with P7 and P13. An ~560 bp unc-22 sequence was 
amplified from genomic DNA with P14 and P15. The fusion product was generated with 
P10 and P16. (b) Prgef-1::unc-22antisense: The rgef-1 promoter was amplified with P7 
and P17. The same ~560 bp unc-22 sequence was amplified from genomic DNA with 
P18 and P19. The fusion product was generated with P10 and P20. A 1:1:1 mix of Prgef-
1::unc-22sense, Prgef-1::unc-22antisense, and Prgef-1::DsRed (0.01 mg/ml each) was 
injected into N2 animals to generate transgenic lines. 
To express rde-1(+) in bwm cells [Pmyo-3::rde-1(+)]: The myo-3 promoter was 
amplified from pHC183 with P21 and P22. The rde-1 coding and 3´UTR sequences were 
amplified from genomic DNA with P23 and P24. The fusion product was generated with 
P25 and P26. A mix of Pmyo-3::rde-1 (0.01 mg/ml) and pHC183 (0.038 mg/ml) was 
injected into WM27, HC70, and HC782 animals with the qtEx136 transgene to generate 
transgenic lines. 
To express mut-2(+) in bwm cells [Pmyo-3::mut-2(+)]: The myo-3 promoter was 
amplified from pHC183 with P21 and P27. The mut-2 coding and 3´UTR sequences 
were amplified from genomic DNA with P28 and P29. The fusion product was generated 
using P25 and P30. A mix of Pmyo-3::mut-2 (0.01 mg/ml) and pHC183 (0.038 mg/ml) 
was injected into WM30 and HC784 animals with the qtEx136 transgene to generate 
transgenic lines. 
To express rde-4(+) in bwm cells [Pmyo-3::rde-4(+)]: The myo-3 promoter was 
amplified from pHC183 with P21 and P31. The rde-4 coding and 3´UTR sequences were 
amplified from genomic DNA with P32 and P33. The fusion products were generated 
with P25 and P34. A mix of Pmyo-3::rde-4 (0.01 mg/ml) and pHC183 (0.038 mg/ml) was injected  into  WM49  and  HC783  animals  with  the  qtEx136  transgene  to  generate 
transgenic lines. 
To  express  rrf-3(+) i n  b w m  c e l l s   [Pmyo-3::rrf-3(+)]:  The  myo-3 p r o m o t e r  w a s  
amplified from pHC183 with P21 and P35. The rrf-3 coding and 3´UTR sequences were 
amplified from genomic DNA with P36 and P37. The fusion product was generated with 
P25  and  P38.  A  mix  of  Pmyo-3::rrf-3 ( 0 . 0 1  m g / m l )  a n d  p H C 1 8 3  ( 0 . 0 3 8  m g / m l )  w a s  
injected into NL2099 animals with the qtEx136 transgene to generate transgenic lines. 
To  express  eri-1(+) i n  b w m cells  [Pmyo-3::eri-1(+)]:  The  myo-3 p r o mo t e r  wa s  
amplified from pHC183 with P21 and P39. The eri-1 coding and 3´UTR sequences were 
amplified from genomic DNA with P40 and P41. The fusion product was generated with 
P25  and  P42.  A  mix  of  Pmyo-3::eri-1 ( 0 . 0 1  m g / m l )  a n d  p H C 1 8 3  ( 0 . 0 3 8  m g / m l )  w as 
injected into GR1373 animals with the qtEx136 transgene to generate transgenic lines. 
To  express  rde-1(+) i n  neuronal  cells  [Prgef-1::rde-1(+)]:  The  rgef-1 p r o m o t e r  
was  amplified  from  genomic  DNA w i t h  P 7 a n d  P43.  The  rde-1  coding  and  3´UTR 
sequences were amplified from genomic DNA with P44 and P24. The fusion product 
was generated with P10 and P26. A mix of Prgef-1::rde-1 (0.01 mg/ml) and pHC183 
(0.038 mg/ml) was injected into WM27 animals with qtEx136 and into HC782 animals 
with qtEx136 to generate transgenic lines. 
To express mut-2(+) in neuronal cells [Prgef-1::mut-2(+)]: The rgef-1 promoter 
was  amplified  from  genomic  DNA w i t h  P 7 a n d  P 45.  The  mut-2 c o d i n g  a n d  3 ´UTR 
sequences were amplified from genomic DNA with P46 and P29. The fusion product 
was generated using P10 and P30. A mix of Prgef-1::mut-2 (0.01 mg/ml) and pHC183 
(0.038 mg/ml) was injected into WM30 animals with qtEx136 and into HC784 animals 
with qtEx136 to generate transgenic lines. 
To  express  rde-4(+) i n  n e u r o n a l  c e l l s  [ Prgef-1::rde-4(+)]:  The  rgef-1 p r o m o t e r  
was  amplified  from  genomic  DNA w i t h  P 7 a n d  P 47.  The  rde-4 c o d i n g  a n d  3 ´UTR 
sequences were amplified from genomic DNA with P48 and P33. The fusion products 
were generated with P10 and P34. A mix of Prgef-1::rde-4 (0.01 mg/ml) and pHC183 
(0.038 mg/ml) was injected into WM49 animals with qtEx136 and into HC783 animals 
with qtEx136 to generate transgenic lines. 
To  express  rrf-1(+) i n  b w m  c e l l s   [Pmyo-3::rrf-1(+)]:  The  myo-3 p r o m o t e r  w a s  
amplified from pHC183 with P21 and P49. The rrf-1 coding and 3´UTR sequences were 
amplified from genomic DNA with P50 and P51. The fusion product was generated with 
P25 a n d  P52.  A  mix  of  Pmyo-3::rrf-1 ( 0 . 0 1  m g / m l )  a n d  p H C 1 8 3  ( 0 . 0 3 8  m g / m l )  w a s  
injected into HC780 animals with the qtEx136 transgene and into HC781 animals with 
the qtEx136 transgene to generate transgenic lines. 
To express dcr-1(+) in bwm cells [Pmyo-3::dcr-1(+)]: The myo-3 promoter was 
amplified from pHC183 with P21 and P53. The dcr-1 coding and 3´UTR sequences were 
amplified from genomic DNA with P54 and P55. A 1:1 mix of the PCR products (0.01 
mg/ml e a c h )  and  pHC183  (0.038  mg/ml)  was  injected  into  HC779 a n i m a l s  w i t h  t h e  
qtEx136 transgene to generate transgenic lines. 
To express dcr-1(+) in neuronal cells [Prgef-1::dcr-1(+)]: The rgef-1 promoter was 
amplified from genomic DNA with P7 and P56. The dcr-1 coding and 3´UTR sequences 
were amplified from genomic DNA with P57 and P55. A 1:1 mix of the PCR products 
(0.01 mg/ml each) and pHC183 (0.038 mg/ml) was injected into HC779 animals with the 
qtEx136 transgene to generate transgenic lines. 
To express DsRed in bwm cells of HC737 animals, 0.038 mg/ml of pHC183 was 
injected to generate transgenic lines. 
In most cases, transgenic lines were easily generated and transgenic animals 
were healthy, and appeared morphologically normal.  
Supplementary Reference 36. Grishok, A. & Sharp, P. A. Negative regulation of nuclear divisions in Caenorhabditis 
elegans by retinoblastoma and RNA interference-related genes. Proc. Natl. Acad. Sci. 
USA 102, 17360-17365 (2005).  
 